Anadarko Petroleum Corporation (APC)

64.18
NYSE
Prev Close 64.18
Day Low/High 0.00 / 0.00
52 Wk Low/High 40.40 / 76.70
Exchange NYSE
Shares Outstanding 501.96B
Market Cap 32.22B
Div & Yield N.A. (N.A)

Video: Jim's Daily Rundown for Wednesday

Jim discusses his views on Anadarko Petroleum, Disney, some winners from the midterm elections, and more.

Looking Past the Election With Some Tradable Ideas

A gridlock scenario, where the House and Senate are controlled by different parties, may serve to offset President Trump's call to raise tariffs on Chinese imports.

Video: Jim Cramer's Daily Rundown for Tuesday

Jim discusses his outlook on oil, Apple and the FANG stocks, the midterm elections, and much more.

Anadarko Petroleum Watching Colorado Midterm

Anadarko Petroleum Watching Colorado Midterm

Proposition 112 could affect Anadarko's future oil production plans in the state.

Weekly Roundup

Markets experienced more volatility this week.

Anadarko To Participate At Upcoming Global Energy Conference

Anadarko To Participate At Upcoming Global Energy Conference

HOUSTON, Nov. 1, 2018 /PRNewswire/ -- Anadarko Petroleum Corporation (NYSE: APC) today announced that Danny Brown, Anadarko Executive Vice President, U.

Buying More Anadarko Petroleum

We believe the stock was overly punished Wednesday relative to the free cash flow it is expected to generate next year.

Video: Jim's Daily Rundown for Wednesday

Jim discusses Facebook's earnings, Apple before earnings on Thursday, Anadarko Petroleum, DowDuPont, Amgen and more!

Anadarko Petroleum Beats on Quarterly Revenue but Falls Short on Earnings

Total production of 682,000 barrels of oil equivalent per day was in line with management's previous guidance.

Anadarko Announces 2018 Third-Quarter Results

Anadarko Announces 2018 Third-Quarter Results

HOUSTON, Oct. 30, 2018 /PRNewswire/ -- Anadarko Petroleum Corporation (NYSE: APC) today announced 2018 third‑quarter results, reporting net income attributable to common stockholders of $363 million, or $0.

Video: Jim's Daily Rundown

Jim discusses BP and Anadarko Petroleum, what to expect from Facebook earnings, the IBM and Red Hat deal, and more!

Staying Long Apple Into Tuesday's Product Launch: Market Recon

Staying Long Apple Into Tuesday's Product Launch: Market Recon

My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.

Anadarko Petroleum Needs to Rebase or Risk Suffering Further Losses

Anadarko Petroleum Needs to Rebase or Risk Suffering Further Losses

Anadarko Petroleum needs to rebase and we need to see the OBV line turn up again.

Trimming Our 3M Position

We view this as an opportunity to trim into strength and allocate cash elsewhere.

Last Week's Portfolio Changes

We exited our position in Cimarex and changed our rating and price target on 3M last week.

Weekly Roundup

Markets were volatile again this week.

Portfolio Review: Taking a Look at Each Name

In light of recent market volatility, we want club members to know our view on every stock we own.

As Good As it Gets?: Cramer's 'Mad Money' Recap (Monday 10/15/18)

As Good As it Gets?: Cramer's 'Mad Money' Recap (Monday 10/15/18)

Jim Cramer says the buzz on the trading floors all over the country is pretty simple: We are late in the cycle of economic expansion.

Beware the Roving Bear: Cramer's 'Mad Money' Recap (Wednesday 9/12/18)

Beware the Roving Bear: Cramer's 'Mad Money' Recap (Wednesday 9/12/18)

Jim Cramer says September brings out the bear in the market and it's searching how to take your money away. Stay diversified and stay the course, he says.

Prudential, Roku, CRISPR Therapeutics: 'Mad Money' Lightning Round

Prudential, Roku, CRISPR Therapeutics: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Prudential, Roku, CRISPR Therapeutics, Oneok, At Home Group, iQIYI, and TransEnterix.

What's the Outlook for Gold? Cramer's 'Off the Charts'

What's the Outlook for Gold? Cramer's 'Off the Charts'

The precious metal is entering its seasonal sweet spot even as global trade turmoil continues.

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at IDEXX Labs, Evolent Health, Triton, Western Gas Partners, Zimmer Biomet and more.

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

Jim Cramer says the tide of selling eventually ebbs, and when it does, stocks rally.

Our Playbook After the Selloff

It may seem difficult to believe given how tough the market has been, but there will be a point in time when fundamentals matter again.

Exiting Cimarex, Buying More Schlumberger and Anadarko Petroleum

We are upgrading the portfolio this afternoon with these oil-related trades.

Weekly Roundup

The markets endured another round of volatility this week.

Anadarko's Correction Looks Over: Time to Do Some Buying

Anadarko's Correction Looks Over: Time to Do Some Buying

Here's when I suggest traders go long on APC.

Weekly Roundup

Markets had one of the most volatile weeks in recent memory.

Jim's Daily Rundown

Jim talks about how the bottoming comes in stages, an early view on bank earnings tomorrow, and more.

Our Game Plan for This Tumultuous Market

Let's review the portfolio and where we see opportunities in the market.

TheStreet Quant Rating: C (Hold)